Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
University of Chicago
University of Chicago
Arcus Biosciences, Inc.
University of Chicago
AstraZeneca
Massachusetts General Hospital
Merck KGaA, Darmstadt, Germany
National Cancer Institute (NCI)
National Cancer Institute (NCI)